T202001 – Donor-specific regulatory T cell therapy in transplantation through CAR engineering Julien Zuber
T202002 – Optimizing Hematopoietic Stem and Progenitor Cells (HSPC) genetic engineering in inflammatory context Dr. Emmanuelle Six
T202003 – Pre-clinical model for the use of universal MAIT cells carrying a chimeric receptor (CAR-MAIT) Sophie Caillat Zucman
T201905 – Use of universal MAIT cells carrying a chimeric receptor (CAR-MAIT) in an allogenic context Dr. Sophie Caillat-Zucman
T201902 – Quality control of advanced therapy products and biological monitoring of patients post gene therapies Capucine Picard
T201901 – Monitoring of the gene therapy efficiency and study of the immunological reconstitution of patients with immune deficits by determining the copy number into the cells Alessandra Magnani
